Acasti Pharma (ACST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACST | SLGL | MGX | ||
| Company | Acasti Pharma | Sol-Gel Technologies Ltd | Metagenomi Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.38 | 75.70 | 1.4800 | ||
| High | 3.45 | 77.22 | 1.5300 | ||
| Low | 3.20 | 72.50 | 1.4700 | ||
| Latest | 3.37 | 73.87 | 1.4800 | ||
| Change | -0.03 | -1.45 | +0.0400 | ||
| % Change | -0.88% | -1.93% | +2.78% | ||
| Volume | 27,800 | 40,500 | 316,100 | ||
| 20-Day Average Volume | 34,930 | 66,230 | 200,490 | ||
| Previous Close | 3.40 | 75.32 | 1.4400 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.24 | 75.63 | 1.3843 | ||
| 20-Day Raw Stochastic | 72.29% | 37.81% | 82.14% | ||
| 20-Day Relative Strength | 58.39 | 48.68 | 52.11 | ||
| Weighted Alpha | +24.36 | +390.12 | -26.18 | ||
| Today's Opinion | 40% Buy | 40% Buy | 72% Sell | ||
| Previous Opinion | 40% Buy | 40% Buy | 88% Sell | ||
| Last Month's Opinion | 8% Sell | 88% Buy | 96% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.20% since 10/18/24 | -1.32% since 04/10/26 | +7.25% since 04/10/26 | ||
| Low | 3.12 on 10/21/24 | 72.02 on 04/13/26 | 1.3800 on 04/13/26 | ||
| High | 3.60 on 10/23/24 | 84.18 on 04/15/26 | 1.5300 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | +10.13% since 09/25/24 | -7.37% since 03/17/26 | +1.37% since 03/17/26 | ||
| Low | 2.77 on 10/01/24 | 61.92 on 03/23/26 | 1.2500 on 03/30/26 | ||
| High | 3.60 on 10/23/24 | 93.53 on 03/24/26 | 1.5300 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | +19.08% since 07/25/24 | +6.29% since 01/16/26 | -10.84% since 01/16/26 | ||
| Low | 2.13 on 09/12/24 | 48.26 on 01/23/26 | 1.2500 on 03/30/26 | ||
| High | 3.60 on 10/23/24 | 97.97 on 03/03/26 | 1.8250 on 03/10/26 | ||
| 6-Month | |||||
| %Chg | +15.08% since 04/25/24 | +81.95% since 10/17/25 | -51.48% since 10/17/25 | ||
| Low | 2.13 on 09/12/24 | 28.81 on 11/13/25 | 1.2500 on 03/30/26 | ||
| High | 3.60 on 10/23/24 | 97.97 on 03/03/26 | 3.3950 on 10/20/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 31,676 | 207,567 | 55,679 | ||
| Shares Outstanding, K | 9,399 | 2,810 | 37,621 | ||
| Annual Sales | 0 | 19,390,000 | 25,210,000 | ||
| Annual Net Income | -12,850,000 | -6,130,000 | -87,870,000 | ||
| Last Quarter Sales | 0 | 700,000 | 3,910,000 | ||
| Last Quarter Net Income | -2,620,000 | -2,990,000 | -22,530,000 | ||
| 60-Month Beta | 1.52 | 1.26 | 0.56 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 08/09/24 | -1.07 on 03/19/26 | -0.60 on 03/05/26 | ||
| Latest Earnings Date | 11/11/24 | 05/22/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||